Glycoprotein E (VZV)

Glycoprotein E (VZV)信息

英文名称:Envelope (E) protein上市药物数量0
中文名称包膜(E)蛋白临床药物数量2
靶点别称gE-1,Envelope glycoprotein E,gE最高研发阶段临床一期
英文名称:Envelope (E) protein
中文名称包膜(E)蛋白
靶点别称gE-1,Envelope glycoprotein E,gE
上市药物数量0
临床药物数量2
最高研发阶段Phase 1 Clinical

Glycoprotein E (VZV)产品列表

  • 属性

    Kits (2)

  • 产品库

    在线 (2)

  • 物种

    Varicella zoster virus (2)

  • 标签

    - (2)

  • 标记

    - (2)

共 2 项数据
  • 1

Glycoprotein E (VZV)分子背景

Varicella-zoster virus (VZV) the etiologic agent of chickenpox and herpes zoster [HZ], is highly contagious and still endemic worldwide. Glycoprotein E (gE) is one of the known glycoproteins (gB, gC, gE, gH, gI, gK, gI) of VZV that is most abundantly expressed on the surface of virus and infected cells, playing an important role in viral replication and cell-to-cell spread. The strongly immunogenic gE can provide strong IgG signal in body fluid, which makes it ideal to be developed as an antigen for analysis of Immunogenicity in the development of VZV vaccine.Therefore,It's helpful to develop the Varicella Zoster Virus Glycoprotein E (VZV gE) ELISA Kit to quantitative detection the VZV gE antigen in vaccine samples during the manufacture and quality control of vaccine development.

Glycoprotein E (VZV)分子别名

gE

产品评论

加载更多
  • 分子信息
  • 产品列表